V2X (VVX) Q4 2025 earnings review
Solid Execution and Deleveraging, But Shrinking Backlog Warrants Caution
V2X delivered a record finish to 2025, with Q4 revenue growing 5% YoY to $1.22 billion and Adjusted EPS surging 17% to $1.56. The company successfully executed its margin and balance sheet strategies, reducing net debt by $116 million and hitting a 2.2x net leverage ratio—comfortably below its 3.0x target. Management established 2026 guidance pointing to accelerating top-line growth (~6%) fueled by major program ramps. However, beneath the surface of record profitability, the Q4 book-to-bill ratio of 0.7x and a $1.4 billion year-over-year contraction in total backlog raise legitimate questions about long-term revenue visibility.
🐂 Bull Case
Adjusted EPS grew 21% in FY25 on just 4% revenue growth, showcasing significant operating leverage and the benefits of a restructured balance sheet that aggressively reduced interest expenses.
Guidance implies revenue growth will accelerate to 6% in 2026 (midpoint), driven by the ramp-up of massive franchise wins like the $4.3B T-6 aviation training program and Iraq F-16 support.
🐻 Bear Case
Total backlog dropped from $12.5B at the end of 2024 to $11.1B at the end of 2025. Q4's book-to-bill ratio of 0.7x contradicts the narrative of unrestrained demand.
Despite a projected 8.7% increase in 2026 Adjusted EPS, Adjusted Operating Cash Flow guidance is essentially stable at $160M (midpoint), up only modestly from $148.3M in FY25, potentially due to elongated government payment cycles.
⚖️ Verdict: ⚪
Cautiously Bullish. V2X is a highly disciplined operator that has masterfully repaired its balance sheet and expanded its bottom line. However, the drop in backlog limits the stock's multiple expansion potential until book-to-bill consistently crosses back above 1.0x.
Key Themes
Balance Sheet Transformation Complete
V2X has successfully transitioned from a heavily indebted integration story to a cash-generating compounder. By generating $182M in operating cash flow in FY25, the company reduced net debt by $116 million YoY down to $758 million. The net leverage ratio is now stable at 2.24x, significantly improving from 2.62x at the end of 2024. This deleveraging drove a massive reduction in interest expense (down to $79.9M from $107.9M), serving as a primary driver for the 21% Adjusted EPS growth.
Deteriorating Book-to-Bill and Backlog
A major red flag is the trajectory of the company's backlog. Total backlog ended 2025 at $11.1B, representing a sharp deceleration from $12.5B at the end of 2024. Furthermore, Q4 book-to-bill registered at a sluggish 0.7x. While management previously noted that large awards are 'episodic' and heavily back-half weighted, failing to achieve a 1.0x ratio in the final quarter indicates that government adjudication delays or protest impacts (such as the T-6 program) are materially constraining visibility.
Major Franchise Ramps Accelerating Top Line
The 6% revenue growth guidance for 2026 reflects the highly anticipated ramp of several massive franchise contracts won over the past 18 months. Programs like the $4.3B T-6 training aircraft support, the Warfighter Training Readiness Solutions (WTRS), and the Iraq F-16 Foreign Military Sales contract are transitioning from procurement to full operational capability. These long-term, fixed-price leaning contracts provide a stable base to offset the sunsetting of legacy programs like the KC-10.
Capital Allocation Pivoting to Shareholder Returns
With the balance sheet repaired and leverage at 2.2x, V2X's capital allocation is shifting. The company executed $30M in treasury stock purchases in FY25 (drawing from the $100M authorization announced in Q2). Moving forward into 2026, management has explicit optionality to accelerate buybacks or pursue strategic bolt-on M&A to acquire niche technological capabilities, rather than dedicating all free cash to debt paydown.
Macro: Elongated Government Payment Cycles
Adjusted operating cash flow guidance for 2026 is $150M-$170M. The $160M midpoint implies an 8% increase over FY25's $148.3M, trailing the expected bottom-line growth. Management noted in Q3 that the government shutdown and general administrative friction elongated collections by approximately 7 days. Flat-to-modest OCF growth indicates that working capital constraints and collection delays remain a persistent headwind.
Other KPIs
Accelerating. After serving as a headwind for much of 2024 and early 2025 due to the sunsetting of the KC-10 and T-1A programs, Air Force revenue rebounded impressively, growing 18.6% YoY compared to FY24 ($481.3M). The ramp of the F-5 adversary program and cockpit modernization efforts drove this reversal.
Stable. Cost-plus and cost-reimbursable contracts accounted for 61% of total revenue ($2.74B), while Firm-fixed-price contributed 36% ($1.61B). This mix is roughly identical to FY24, showing that despite management's stated goal of transitioning to higher-margin fixed-price outcomes, the legacy cost-plus base remains the dominant revenue driver.
Guidance
Accelerating. The midpoint of $4.75 billion represents 6.0% YoY growth, a clear step up from the 3.7% growth achieved in FY25. This acceleration is underpinned by a massive $50B+ pipeline and the activation of previously won multi-billion dollar franchise programs.
Stable. The midpoint of $343 million implies a 6.1% YoY growth, perfectly matching revenue growth. This translates to an implied Adjusted EBITDA margin of exactly 7.2%—identical to the 7.2% achieved in FY24 and FY25, indicating that margin expansion has plateaued as new programs ramp up at initially lower margins.
Decelerating growth rate, but still robust. The midpoint of $5.70 implies 8.8% YoY growth. While highly respectable, this is a deceleration from the massive 20.7% growth seen in FY25, as the easy year-over-year comparisons from debt interest reduction have largely been realized.
Key Questions
Backlog Contraction Dynamics
Total backlog declined by $1.4 billion year-over-year, and Q4 book-to-bill was only 0.7x. How much of this is driven by delayed adjudications versus market share losses, and when do you expect the TTM book-to-bill to cross back above 1.0x?
Margin Ceiling
With 2026 Adjusted EBITDA margins implied to be flat at 7.2% for the third consecutive year, what specific catalysts are required to break through this plateau? Is the transition to fixed-price contracts happening slower than anticipated?
Capital Deployment Priorities
Having comfortably achieved the 2.2x net leverage ratio, how does the board weigh the aggressiveness of the $100M share repurchase program against bolt-on M&A opportunities in the current valuation environment?